C12Y 204/00
Glycosyltransferases
Official title: Glycosyltransferases (2.4)
C12Y204/00 (Glycosyltransferases) appears on 1,109 US grants and 2,040 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1,109
- Published applications
- 2,040
- Assignees
- 841
- Inventors
- 4,125
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 1 | 0 |
| 1998 | 6 | 0 |
| 1999 | 11 | 0 |
| 2000 | 10 | 0 |
| 2001 | 14 | 0 |
| 2002 | 15 | 15 |
| 2003 | 9 | 25 |
| 2004 | 9 | 22 |
| 2005 | 8 | 16 |
| 2006 | 7 | 22 |
| 2007 | 8 | 15 |
| 2008 | 8 | 13 |
| 2009 | 10 | 24 |
| 2010 | 14 | 27 |
| 2011 | 14 | 41 |
| 2012 | 16 | 27 |
| 2013 | 16 | 60 |
| 2014 | 28 | 55 |
| 2015 | 47 | 97 |
| 2016 | 63 | 117 |
| 2017 | 47 | 153 |
| 2018 | 72 | 143 |
| 2019 | 92 | 151 |
| 2020 | 114 | 120 |
| 2021 | 84 | 156 |
| 2022 | 87 | 138 |
| 2023 | 62 | 133 |
| 2024 | 80 | 198 |
| 2025 | 82 | 154 |
| 2026 | 59 | 118 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition and methods related to modification of 5 hydroxymethylcytosine (5-hmC)6 Oct 2026US 12,753,445 B2The University of Chicago
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Culture compositions and methods of their use for high yield production of vanillin22 Sep 2026US 12,742,186 B2Amyris, Inc.
- Production of fructose from oligo-/ and/or polysaccharides22 Sep 2026US 12,742,190 B2Archer Daniels Midland Company
- Glycosyltransferase mutant, and method for catalytic synthesis of rebaudioside m using glycosyltransferase mutant15 Sep 2026US 12,735,684 B2Xinghua Gl Stevia Co., Ltd
- Method for producing plant-based cheese8 Oct 2026US 2026/0305639 A1Amano Enzyme Inc.
- Methods of treating neurodegenerative disorders8 Oct 2026US 2026/0306669 A1
- Chemoenzymatic method for the detection of cell-cell proximity interaction and isolation of tumor-specific antigen reactive t cells for immune therapy8 Oct 2026US 2026/0308537 A1The Scripps Research Institute
- Engineering gt2 type of membrane proteins for targeting to the tonoplast, and engineering sorghum to synthesize and deposit mixed-linkage glucan (mlg) in the vacuole8 Oct 2026US 2026/0308607 A1Board of Trustees of Michigan State University
- Novel biosynthesis system for producing 3'-phosphoadenosine-5'-phosphosulfate and application thereof8 Oct 2026US 2026/0308651 A1Jiangnan University
Most cited
By later US patents
- Cells producing antibody compositions with increased antibody dependent cytotoxic activity247US 6,946,292 B2Kyowa Hakko Kogyo Co., Ltd. · 2005
- Polysaccharide fibers157US 7,000,000 B1E. I. Du Pont de Nemours and Company · 2006
- Biocompatible implant for the expression and in vivo secretion of a therapeutic substance151US 5,906,817 AInstitut Pasteur · 1999
- Combined use of .beta.-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides130US 5,374,541 ACytel Corporation · 1994
- Antibodies against CD38 for treatment of multiple myeloma94US 7,829,673 B2Genmab A/S · 2010